| 1 |
28827188 | Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer. | 2018 Feb |
2 |
| 2 |
29210644 | Carboxylesterase Inhibitors: An Update. | 2018 |
1 |
| 3 |
28126414 | Recent progress in the discovery of natural inhibitors against human carboxylesterases. | 2017 Mar |
1 |
| 4 |
27569869 | The role of pharmacogenetics in capecitabine efficacy and toxicity. | 2016 Nov |
1 |
| 5 |
18473752 | A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression. | 2008 May |
5 |
| 6 |
15687373 | Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. | 2005 Jun |
7 |